Vaxcyte, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vaxcyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
  • Vaxcyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$103M, a 11.3% decline year-over-year.
  • Vaxcyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$508M, a 69.5% decline year-over-year.
  • Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$402M, a 80% decline from 2022.
  • Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223M, a 123% decline from 2021.
  • Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$100M, a 12.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$402M -$179M -80% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$223M -$123M -123% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$100M -$10.9M -12.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$89.2M -$38.9M -77.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$50.3M -$20.8M -70.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$29.5M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.